tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

PODDInsulet Corporation

Health care · Medical Instruments · Nasdaq
Compare with peers → Embed
Cash returned and share count, year to Dec 31, 2025

Bought back $59.6M of its own shares, 0.9× what it paid in stock

XBRL, latest 10-K
Buybacks
$59.6M
cash paid for its own shares
Paid in stock to employees
$62.7M
stock-based compensation
Share count, 1 year
-2.7%
fewer shares: each share owns more
Share count, 3 years
+2.8%
diluted average shares
New shares against shares bought back

Dilution: new shares, stock pay and buybacks

S-3 and 424B, 3 years; 10-K

Shares offered

No S-3 or 424B prospectus for shares since Nov 12, 2023.

Paid in stock

$62.7M

stock-based pay, year to Dec 31, 2025; shares sold for $19.0M in cash

Bought back

$59.6M

cash paid for its own shares, year to Dec 31, 2025: 0.9× the stock pay

Diluted shares: 71.89M in the year to Dec 31, 2025 2025 -2.7%2024 +0.4%2023 +5.3%2022 +1.9%

Change in the diluted weighted average share count from the fiscal year before, stock splits taken out. Bars use one scale for stock pay and buybacks. Prospectuses are read from their cover page; preliminary ones are left out. Cash & buybacks, year by year → · How

Where the cash went

Where the cash came from and where it went

10-K cash flow statement

FY2025, from the cash flow statement in the 10-K, added up.

Operating cash flowDebt raisedShares soldCash on hand usedCapital spendingBuybacksOther, net Operating cash flow: $569.3M Operating cash flow $569.3M Debt raised: $440.7M Debt raised $440.7M Shares sold: $19.0M Shares sold $19.0M Cash on hand used: $237.3M Cash on hand used $237.3M Capital spending: $191.6M Capital spending $191.6M Buybacks: $59.6M Buybacks $59.6M Other, net: $1.0B Other, net $1.0B

Each number is a line of the cash flow statement as the company tagged it. "Other, net" is what those lines do not cover (investments bought and sold, other financing and investing lines, and exchange rates); Tickdelta does not estimate it.

Each CEO's years

What the 10-Ks show for each CEO's years

Proxy and 10-Ks

The CEO of each fiscal year as named in the proxy's pay versus performance table, and what the 10-Ks show for those years.

Ashley McEvoy

FY2025 · 1 year in the table
Operating cash flow
$569.3M
Capital spending
$191.6M
Buybacks
$59.6M
Stock-based pay
$62.7M
Diluted shares since FY2024
-2.7%
Revenue since FY2024
+31%
Debt since FY2024
-$430.7M
CEO pay (reported)
$32.1M
The proxy that names the CEO ↗

James Hollingshead

FY2022 to FY2024 · 3 years in the table
Operating cash flow
$694.9M
Capital spending
$323.4M
Acquisitions
$29.0M
Buybacks
$0
Stock-based pay
$158.6M
Diluted shares since FY2021
+7.7%
Revenue since FY2021
+89%
Debt since FY2021
+$106.0M
CEO pay (reported)
$52.2M
The proxy that names the CEO ↗

Shacey Petrovic

FY2021 · 1 year in the table
Operating cash flow
-$68.1M
Capital spending
$111.9M
Stock-based pay
$34.4M
Diluted shares since FY2020
+4.0%
Revenue since FY2020
+21%
Debt since FY2020
+$214.6M
CEO pay (reported)
$9.7M
The proxy that names the CEO ↗
Year by year

Buybacks, dividends and share count

XBRL, each 10-K
Fiscal year toBuybacksDividendsStock payShares issued for cashDiluted shares
2025-12-31$59.6M -$62.7M $19.0M71.89M
2024-12-31$0 -$69.3M $8.2M73.89M
2023-12-31$0 -$48.4M $16.3M73.63M
2022-12-31- -$40.9M $069.91M
2021-12-31- -$34.4M $068.58M

From the XBRL of the 10-Ks (cash flow statement and diluted weighted average shares); each year as reported in the latest 10-K that includes it. Concepts: buybacks = PaymentsForRepurchaseOfCommonStock; sbc = ShareBasedCompensation; issuance = ProceedsFromStockOptionsExercised; diluted_shares = WeightedAverageNumberOfDilutedSharesOutstanding.

Next CEO pay →